Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lifecore Biomedical (LFCR) Operating Margin: 2009-2025

Historic Operating Margin for Lifecore Biomedical (LFCR) over the last 16 years, with May 2025 value amounting to 14.62%.

  • Lifecore Biomedical's Operating Margin rose 894.00% to 14.62% in Q2 2025 from the same period last year, while for May 2025 it was -13.38%, marking a year-over-year decrease of 649.00%. This contributed to the annual value of -13.38% for FY2025, which is 649.00% down from last year.
  • Latest data reveals that Lifecore Biomedical reported Operating Margin of 14.62% as of Q2 2025, which was up 156.91% from -25.68% recorded in Q1 2025.
  • Lifecore Biomedical's Operating Margin's 5-year high stood at 14.62% during Q2 2025, with a 5-year trough of -46.89% in Q3 2024.
  • In the last 3 years, Lifecore Biomedical's Operating Margin had a median value of -13.66% in 2023 and averaged -14.68%.
  • Its Operating Margin has fluctuated over the past 5 years, first skyrocketed by 2,784bps in 2021, then plummeted by 3,889bps in 2022.
  • Quarterly analysis of 5 years shows Lifecore Biomedical's Operating Margin stood at 14.41% in 2021, then plummeted by 3,889bps to -24.48% in 2022, then soared by 1,956bps to -4.92% in 2023, then crashed by 110bps to -6.02% in 2024, then soared by 894bps to 14.62% in 2025.
  • Its last three reported values are 14.62% in Q2 2025, -25.68% for Q1 2025, and -6.02% during Q4 2024.